Induced Abortion: An Overview for Internists

Annals of Internal Medicine

Volumn 140, Issue 8, 2004, Pages 620-626

  Grimes, David A ^a   Creinin, Mitchell D ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; IBUPROFEN; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ABORTION; ADULT; BLEEDING; BREAST CANCER; CAUCASIAN; CLINICAL TRIAL; CONTRACEPTION; CURETTAGE; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; EMERGENCY TREATMENT; FATALITY; FEMALE; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH SERVICE; HEMATOMETRA; HUMAN; INCOMPLETE ABORTION; INDUCED ABORTION; INFECTION; INTERNAL MEDICINE; INTERNIST; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MENTAL DISEASE; NATIONAL ABORTION FEDERATION; OUTPATIENT DEPARTMENT; PAIN; PATIENT REFERRAL; PLANNED PARENTHOOD FEDERATION OF AMERICA; PRIORITY JOURNAL; REVIEW; SAFETY; SINGLE PARENT;

EID: 16544392703     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-8-200404200-00009     Document Type: Review

References (49)

1. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30:24-9, 46. [PMID: 9494812]
2. Stedman's Medical Dictionary. Philadelphia: Lippincott Williams & Wilkins; 2000.
3. Elam-Evans LD, Strauss LT, Herndon J, Parker WY, Whitehead S, Berg CJ. Abortion surveillance-United States, 1999. MMWR Surveill Summ. 2002;51: 1-9, 11-28. [PMID: 12495293]
4. Cates W, Grimes DA, Schulz KF. Abortion surveillance at CDC: creating public health light out of political heat. Am J Prev Med. 2000;19:12-7. [PMID: 10863125]
5. Jones RK, Darroch JE, Henshaw SK. Patterns in the socioeconomic characteristics of women obtaining abortions in 2000-2001. Perspect Sex Reprod Health. 2002;34:226-35. [PMID: 12392215]
6. Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health. 2002;34:294-303. [PMID: 12558092]
7. Creinin MD. Medical abortion regimens: historical context and overview. Am J Obstet Gynecol. 2000;183:S3-9. [PMID: 10944364]
8. Lichtenberg ES, Paul M, Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2001;64: 345-52. [PMID: 11834232]
9. Singh K, Fong YF, Prasad RN, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;92:795-8. [PMID: 9794671]
10. Paul M, Lackie E, Mitchell C, Rogers A, Fox M. Is pathology examination useful after early surgical abortion? Obstet Gynecol. 2002;99:567-71. [PMID: 12039112]
11. Wiebe E, Dunn S, Guilbert E, Jacot F, Lugtig L. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol. 2002;99:813-9. [PMID: 11978292]
12. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod. 2002;17:1477-82. [PMID: 12042265]
13. Bygdeman M, Swahn ML. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception. 1985;32:45-51. [PMID: 4053605]
14. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92. [PMID: 9207820]
15. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception. 2001;64:81-5. [PMID: 11704083]
16. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 1995;332:983-7. [PMID: 7885426]
17. Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;328:1509-13. [PMID: 8479487]
18. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998; 338:1241-7. [PMID: 9562577]
19. Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. BMJ. 1993;307:532-7. [PMID: 8400972]
20. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. BJOG. 2000;107:524-30. [PMID: 10759273]
21. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000;61:41-6. [PMID: 10745068]
22. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;59:1-6. [PMID: 10342079]
23. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. 1997; 44:353-60. [PMID: 9108832]
24. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA. 2000;284:1948-53. [PMID: 11035891]
25. Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception. 2001;63:255-6. [PMID: 11448465]
26. Creinin MD, Shulman T. Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion. Contraception. 1997; 56:165-8. [PMID: 9347207]
27. Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, eds. A Clinician's Guide to Medical and Surgical Abortion. New York: Churchill Livingstone; 1999.
28. Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Silvestre L, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected]. Int J Fertil Menopausal Stud. 1995;40 Suppl 2:85-91. [PMID: 8574255]
29. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod. 1993;8:1502-5. [PMID: 8253942]
30. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol. 1992;99:1004-7. [PMID: 1477003]
31. Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. J Am Med Womens Assoc. 2000;55:141-4. [PMID: 10846324]
32. Herndon J, Strauss LT, Whitehead S, Parker WY, Bartlett L, Zane S. Abortion surveillance - United States, 1998. MMWR Surveill Summ. 2002;51: 1-32. [PMID: 12369584]
33. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol. 1994;171:1365-72. [PMID: 7977548]
34. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76:129-35. [PMID: 2359559]
35. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 1996;87:884-90. [PMID: 8677129]
36. de Groot AN, van Dongen PW, Vree TB, Hekster YA, van Roosmalen J. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs. 1998;56:523-35. [PMID: 9806101]
37. Atrash HK, Hogue CJ. The effect of pregnancy termination on future reproduction. Baillieres Clin Obstet Gynaecol. 1990;4:391-405. [PMID: 2225607]
38. Adler NE, David HP, Major BN, Roth SH, Russo NF, Wyatt GE. Psychological responses after abortion. Science. 1990;248:41-4. [PMID: 2181664]
39. Westhoff C, Picardo L, Morrow E. Quality of life following early medical or surgical abortion. Contraception. 2003;67:41-7. [PMID: 12521657]
40. Stotland NL. The myth of the abortion trauma syndrome. JAMA. 1992;268: 2078-9. [PMID: 1404747]
41. Bartholomew LL, Grimes DA. The alleged association between induced abortion and risk of breast cancer: biology or bias? Obstet Gynecol Surv. 1998; 53:708-14. [PMID: 9812330]
42. Finer LB, Henshaw SK. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health. 2003;35:6-15. [PMID: 12602752]
43. Grimes DA, Cates W Jr, Selik RM. Abortion facilities and the risk of death. Fam Plann Perspect. 1981;13:30-2. [PMID: 7215517]
44. Henshaw SK, Finer LB. The accessibility of abortion services in the United States, 2001. Perspect Sex Reprod Health. 2003;35:16-24. [PMID: 12602753]
45. Shelton JD, Brann EA, Schulz KF. Abortion utilization: does travel distance matter? Fam Plann Perspect. 1976;8:260-2. [PMID: 1001409]
46. Mertus JA. Fake abortion clinics: the threat to reproductive self-determination. Women Health. 1990;16:95-113. [PMID: 2309498]
47. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. 1997;96:358-66. [PMID: 9236458]
48. Forrest JD, Henshaw SK. Providing controversial health care: abortion services since 1973. Womens Health Issues. 1993;3:152-7. [PMID: 8274870]
49. Alan Guttmacher Institute. State policies in brief. State funding of abortion under Medicaid. Accessed at www.guttmacher.org/pubs/spib_SFAM.pdfon 10 July 2003.